Tag: Trial

VCU Health leads clinical trial of new treatment to help people with bowel control issues

olivia torani A research team at VCU Health is leading a clinical trial evaluating new treatments for fecal incontinence and sudden loss of bowel control. The treatment involves implanting a bioengineered sphincter muscle derived from the patient’s natural cells to help the patient regain control of his or her bowels. The transplant surgery for the […]

BMS completes Phase 3 trial of nivolumab and leratorimab for colorectal cancer

Colorectal cancer: © Peterschreiber.media – Stock.adobe.com Bristol-Myers Squibb is conducting a Phase 3 RELATIVITY study investigating nivolumab (Opdivo) and relatlimab (Opdualag) in patients with previously treated metastatic microsatellite stable (MSS) colorectal cancer (CRC). -123 study (NCT05328908) has been completed and will not progress beyond 1. It is more effective than 4-line treatment because it is […]

BMS’s Opdivo meets co-primary endpoint in colorectal cancer trial

Despite Opdivo’s success in combination trials, Bristol-Myers Squibb faces challenges as Opdivo’s European and U.S. patents expire in 2026 and 2028, respectively, threatening sales growth. There is. Credit: Dennis Diatel, via ShutterStock. Bristol-Myers Squibb (BMS) announced that its Phase III CheckMate-8HW study of Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the treatment of metastatic […]

Oncolytics Biotech Inc. Announces Anal Cancer Cohort of Peraleolep and Atezolizumab Goblet Phase 1/2 Clinical Trial Meets Efficacy Criteria – November 9, 2023, 7:01 a.m. EST

Oncolytics Biotech Inc. announces positive interim results from the Phase 1/2 GOBLET trial evaluating the combination of perolep and atezolizumab in second-line patients with unresectable anal canal squamous cell carcinoma, led by Dirk Arnold, MD. It was announced that it was announced. Director of the Asklepios Oncology Center in Hamburg and principal investigator of the […]

New trial for colorectal cancer: could your patient benefit?

some clinical trials colorectal cancer I started recently. Perhaps some of your patients are eligible to participate. Lynch syndrome At least 6 months have passed since any cancer-directed treatment. Adult patients with this hereditary cancer syndrome will be included in a randomized controlled phase 2b study at the National Cancer Institute. This trial evaluates whether […]

Appendicitis Disease Market: Regional Coverage, Drug Insights, Epidemiological Studies, Clinical Trial Evaluation, and Price Reimbursement

London, October 12, 2023 /PRNewswire/ — appendicitis disease It is a common disease caused by an inflamed appendix. According to NIH research, approximately 5 to 9 out of 100 people will develop the disorder at some point. Due to the high disease burden, effective diagnostic and therapeutic methods are urgently needed. Landscape of illness_insight_logo Appendicitis […]

Motixafortide shows efficacy as primary treatment for pancreatic cancer in phase 2 trial

Pancreas image | Image credit: © Лилия Захарчук – Stock.adobe.com Motixafortide, a CXC4 inhibitor, when combined with the PD-1 inhibitor cemiplimab and the standard of care (SoC) chemotherapy treatment gemcitabine and nab-paclitaxel (MCGN) Phase 2 Data from the CheMo4METPANC trial (NCT04543071) showed some positive results against (mPDAC). This data, presented as an abstract as part […]

MSK’s rectal cancer clinical trial changed everything for patients

“I always dreamed of having a big family.” For Kelly Spill, learning that she has rectal cancer didn’t just mean facing a potentially life-threatening disease. The diagnosis also threatened many of the things she valued most in life. Kelly was diagnosed at age 28, just months after giving birth to her son Jace. She and […]

Ride Cincinnati supports UC clinical trial to help anal cancer patients

Jordan Calofa, MD, a physician and scientist at the University of Cincinnati Cancer Center, has been searching for better ways to treat anal cancer patients for nearly a decade. Anal cancer is still considered a rare disease, even though its incidence is increasing. “This is considered one of the most difficult cancers to treat patients,” […]